[Not Available].
作者信息
Marwah Radhika, Coons Caitlin, Myers Jacqueline, Dumont Zack
机构信息
Staff physician with the Interprofessional Pain and Addictions Recovery Clinic at the Centre for Addiction and Mental Health in Toronto, Ont.
Pharmacist with the Saskatchewan Health Authority in Regina.
出版信息
Can Fam Physician. 2020 Dec;66(12):891-894. doi: 10.46747/cfp.6612891.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Can Fam Physician. 2020 Dec;66(12):891-894. doi: 10.46747/cfp.6612891.
2
High-dose buprenorphine for treatment of high potency opioid use disorder.高剂量丁丙诺啡治疗高效阿片类药物使用障碍。
Drug Alcohol Rev. 2020 Feb;39(2):135-137. doi: 10.1111/dar.13017. Epub 2019 Nov 25.
3
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.成功将使用非法芬太尼的个体诱导到丁丙诺啡/纳洛酮上的方法。
Am J Addict. 2021 Jan;30(1):83-87. doi: 10.1111/ajad.13069. Epub 2020 Jun 23.
4
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.丁丙诺啡/纳洛酮与美沙酮及洛非西定用于社区稳定治疗和脱毒：低剂量短期阿片类药物依赖个体的随机对照试验
J Psychopharmacol. 2017 Aug;31(8):1046-1055. doi: 10.1177/0269881117711710. Epub 2017 Jun 20.
5
A buprenorphine-naloxone induction in the North.在北方进行的丁丙诺啡-纳洛酮诱导。
Can J Rural Med. 2021 Jan-Mar;26(1):35-37. doi: 10.4103/CJRM.CJRM_10_20.
6
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.在住院环境中快速微量诱导丁丙诺啡/纳洛酮治疗阿片类药物使用障碍：病例系列研究。
Am J Addict. 2019 Jul;28(4):262-265. doi: 10.1111/ajad.12869. Epub 2019 Mar 22.
7
Buprenorphine-naloxone.丁丙诺啡-纳洛酮
CMAJ. 2018 Nov 26;190(47):E1389. doi: 10.1503/cmaj.180776.
8
The use of buprenorphine + naloxone sublingual tablet in the treatment of neonatal opioid withdrawal syndrome: Two case reports.丁丙诺啡/纳洛酮舌下片治疗新生儿阿片类戒断综合征：两例报告。
J Addict Dis. 2022 Jul-Sep;40(3):432-438. doi: 10.1080/10550887.2021.1987784. Epub 2021 Nov 13.
9
Sublingual buprenorphine-naloxone precipitated withdrawal-A case report with review of literature and clinical considerations.舌下含服丁丙诺啡 - 纳洛酮诱发的戒断反应——一例病例报告并文献复习及临床思考
Asian J Psychiatr. 2020 Oct;53:102121. doi: 10.1016/j.ajp.2020.102121. Epub 2020 May 16.
10
Management of chronic pain and opioid dependence with buprenorphine/naloxone.用丁丙诺啡/纳洛酮治疗慢性疼痛和阿片类药物依赖
Psychiatry Clin Neurosci. 2018 Jun;72(6):454. doi: 10.1111/pcn.12652. Epub 2018 Apr 10.
引用本文的文献
1
Navigating Buprenorphine Therapy: A Closer Look at Microdosing vs. Macrodosing for Pain Management and Opioid Addiction - A Narrative Review.丁丙诺啡疗法解读：深入探讨微剂量与大剂量疗法在疼痛管理及阿片类药物成瘾治疗中的应用——一篇叙述性综述
Addict Health. 2024 Oct;16(4):279-285. doi: 10.34172/ahj.1590. Epub 2024 Oct 29.
2
Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report.在一名老年患者的慢性疼痛和偏头痛管理中，使用低剂量方案成功将布托啡诺鼻喷雾剂转换为丁丙诺啡/纳洛酮，以辅助阿片类药物减量：一例报告。
Can J Pain. 2022 Aug 18;6(1):135-141. doi: 10.1080/24740527.2022.2090911. eCollection 2022.
本文引用的文献
1
Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report.丁丙诺啡/纳洛酮采用微剂量方案诱导治疗慢性疼痛急性发作：一例报告。
Can J Pain. 2019 Apr 25;3(1):79-84. doi: 10.1080/24740527.2019.1599279. eCollection 2019.
2
Managing opioid use disorder in primary care: PEER simplified guideline.初级保健中阿片类药物使用障碍的管理：PEER简化指南。
Can Fam Physician. 2019 May;65(5):321-330.
3
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.在住院环境中快速微量诱导丁丙诺啡/纳洛酮治疗阿片类药物使用障碍：病例系列研究。
Am J Addict. 2019 Jul;28(4):262-265. doi: 10.1111/ajad.12869. Epub 2019 Mar 22.
4
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method.在重叠使用全效阿片类激动剂的情况下，使用微剂量诱导丁丙诺啡治疗：伯尔尼方法。
Subst Abuse Rehabil. 2016 Jul 20;7:99-105. doi: 10.2147/SAR.S109919. eCollection 2016.
5
The Clinical Opiate Withdrawal Scale (COWS).临床阿片戒断量表（COWS）。
J Psychoactive Drugs. 2003 Apr-Jun;35(2):253-9. doi: 10.1080/02791072.2003.10400007.
Zotero 插件